Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6863
Gene Symbol: TAC1
TAC1 		0.300 Therapeutic phenotype CTD_human Scopolamine- and diazepam-induced amnesia are blocked by systemic and intraseptal administration of substance P and choline chloride. 20600432 2010
Entrez Id: 4803
Gene Symbol: NGF
NGF 		0.300 Therapeutic phenotype CTD_human Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. 19694610 2009
Entrez Id: 4803
Gene Symbol: NGF
NGF 		0.300 Therapeutic phenotype CTD_human [Antiamnesic activity of nerve growth factor adsorbed on poly(butyl) cyanoacrylate nanoparticles coated with polysorbate-80]. 16405025 2006
Entrez Id: 351
Gene Symbol: APP
APP 		0.300 Biomarker phenotype CTD_human Anti-amnesic effect of dimemorfan in mice. 12642396 2003
Entrez Id: 10280
Gene Symbol: SIGMAR1
SIGMAR1 		0.300 Therapeutic phenotype CTD_human Strain differences in sigma(1) receptor-mediated behaviours are related to neurosteroid levels. 12028363 2002
Entrez Id: 2922
Gene Symbol: GRP
GRP 		0.300 Therapeutic phenotype CTD_human Posttraining administration of gastrin-releasing peptide improves memory loss in scopolamine- and hypoxia-induced amnesic mice. 11564462 2001
Entrez Id: 2770
Gene Symbol: GNAI1
GNAI1 		0.300 Biomarker phenotype CTD_human Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunits. 11350863 2001
Entrez Id: 2773
Gene Symbol: GNAI3
GNAI3 		0.300 Biomarker phenotype CTD_human Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunits. 11350863 2001
Entrez Id: 11255
Gene Symbol: HRH3
HRH3 		0.300 Biomarker phenotype CTD_human Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia. 11125734 1999
Entrez Id: 6863
Gene Symbol: TAC1
TAC1 		0.300 Therapeutic phenotype CTD_human Posttraining administration of substance P and its N-terminal fragment block the amnestic effects of diazepam. 9521815 1998
Entrez Id: 3569
Gene Symbol: IL6
IL6 		0.300 Therapeutic phenotype CTD_human Interleukin-6 affects scopolamine-induced amnesia, but not brain amino acid levels in mice. 9189931 1997
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.300 Therapeutic phenotype CTD_human Peripherally administered GM-CSF interferes with scopolamine-induced amnesia in mice: involvement of interleukin-1. 8877002 1996
Entrez Id: 5550
Gene Symbol: PREP
PREP 		0.300 Biomarker phenotype CTD_human New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives. 8691432 1996
Entrez Id: 5173
Gene Symbol: PDYN
PDYN 		0.300 Therapeutic phenotype CTD_human Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in mice. 7768285 1995
Entrez Id: 551
Gene Symbol: AVP
AVP 		0.300 Therapeutic phenotype CTD_human JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. 7562510 1995
Entrez Id: 7200
Gene Symbol: TRH
TRH 		0.300 Therapeutic phenotype CTD_human JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. 7562510 1995
Entrez Id: 7200
Gene Symbol: TRH
TRH 		0.300 Therapeutic phenotype CTD_human NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats. 7617693 1995
Entrez Id: 6863
Gene Symbol: TAC1
TAC1 		0.300 Therapeutic phenotype CTD_human JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. 7562510 1995
Entrez Id: 3558
Gene Symbol: IL2
IL2 		0.300 Biomarker phenotype CTD_human Interleukin-2 enhances scopolamine-induced amnesia and hyperactivity in the mouse. 8241462 1993
Entrez Id: 3552
Gene Symbol: IL1A
IL1A 		0.300 Therapeutic phenotype CTD_human Peripherally administered IL-1 alpha interferes with scopolamine-induced amnesia in mice. 8003924 1993
Entrez Id: 7200
Gene Symbol: TRH
TRH 		0.300 Therapeutic phenotype CTD_human Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents. 8405091 1993
Entrez Id: 5443
Gene Symbol: POMC
POMC 		0.300 Biomarker phenotype CTD_human Post-training and pretest effects of adrenocorticotropin on retention: the influence of the hour of the day, the training-test interval, and pretest naloxone administration. 2841920 1988